FTX missed the $100 billion IPO of Anthropic

Anthropic has publicly submitted and updated its prospectus (S-1/A) to the U.S. Securities and Exchange Commission, planning to go public on Nasdaq under the stock ticker ANT, with Goldman Sachs and Morgan Stanley serving as lead underwriters. The latest amendment submitted on November 10 reveals an offering price range of $70 to $78 per share, with approximately 825 million shares of Class A common stock being offered, of which the company will issue about 801.35 million shares, existing shareholders will sell about 23.65 million shares, and underwriters will have an additional overallotment option of about 123.75 million shares. The company will also allocate approximately $26 billion of non-voting Class N shares to strategic investors such as Google, Nvidia, AMD, Broadcom, Micron, Microsoft, and TSMC, priced in line with the IPO price.

The market expects pricing around November 18, with trading potentially starting on November 19. Based on approximately 1.309 billion shares post-offering, this corresponds to a valuation of about $917 billion to $1.02 trillion; accounting for options, restricted stock, and other fully diluted factors, the high-end valuation could reach about $1.4 trillion. Previously, the market anticipated a fundraising scale of about $100 billion, with a maximum valuation reaching $2 trillion, but the latest terms have narrowed.

FTX-affiliated Alameda Research acquired approximately 7.84% of Anthropic for about $500 million between 2021 and 2022, corresponding to about 44.54 million shares of Series B. After FTX filed for bankruptcy protection in November 2022, the bankruptcy estate sold about 29.5 million shares in March 2024 for a total transaction amount of about $884 million, and in June sold another approximately 15 million shares, recovering about $452 million, totaling about $1.34 billion. According to the latest prospectus's fully diluted share count, the original ownership percentage has decreased to about 2.5%, corresponding to a theoretical value of about $3.11 billion to $3.47 billion based on the IPO price range.